APX Charts, page-1670

Talking about not understanding the company using catch phrases and soundibites.

Fact 1 - CSL EPS is expected to grow 20% over the next three years which gives it a 6.67% annual growth rate - this is on a P/E of FY21e @ 52 .. you expect to pay a bit of premium for quality but facto f the matter is that NPAT hasnt grown alot past three years and projected NPAT growth next three years will hardly change - considering its on a 35 EV/EBITDA its not exactly cheap but dont expect CSL to ever be cheap. Maybe one day.

Fact - 2 same method EPS is expected to grow 50% over next three years that gives it a 16.67% annual growth rate. - this is on a P/E of CY21e @ 35.. NPAT is expected to grow from $50M CY20 to $95M CY23e on EV/EBITDA CY21e @ 16.5x

APX being savagely downgraded could be seen as a curse or a gift. Time will tell.

These are not my numbers they are analyst averages that you can find at S&P Global Market Intelligence.